| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/12/2022 | ChargePoint Holdings, Inc. | SBE | Grant | Common Stock | 13.6k | $0.00 | $0 | | 07/12/2022 |
| 07/12/2021 | ChargePoint Holdings, Inc. | SBE | Grant | Common Stock | 3.2k | $0.00 | $0 | | 07/12/2021 |
| 07/01/2021 | ChargePoint Holdings, Inc. | SBE | Other (acquisition) | Common Stock | 12.6k | $0.00 | $0 | By LLC | 07/01/2021 |
| 06/08/2021 | NGM BIOPHARMACEUTICALS INC | NGM | Grant | Stock Option (Right to Buy) | 19.6k | $17.24 | $338.2k | | 06/08/2021 |
| 05/27/2021 | ChargePoint Holdings, Inc. | SBE | Grant | Common Stock | 18.5k | $0.00 | $0 | | 05/27/2021 |
| 03/19/2021 | ChargePoint Holdings, Inc. | SBE | Other (acquisition) | Common Stock | 25.3k | $0.00 | $0 | By LLC | 03/19/2021 |
| 02/26/2021 | ChargePoint Holdings, Inc. | SBE | Grant | Common Stock | 383k | $0.00 | $0 | See Footnote | 02/26/2021 |
| 05/20/2020 | NGM BIOPHARMACEUTICALS INC | NGM | Grant | Stock Option (Right to Buy) | 16.8k | $20.37 | $342.3k | | 05/20/2020 |
| 05/15/2019 | NGM BIOPHARMACEUTICALS INC | NGM | Grant | | 24k | $13.35 | $320.4k | | 05/15/2019 |
| 04/08/2019 | NGM BIOPHARMACEUTICALS INC | NGM | Conversion | Series C Preferred Stock | 166.7k | $0.00 | $0 | See Footnotes | 04/08/2019 |
| 04/08/2019 | NGM BIOPHARMACEUTICALS INC | NGM | Conversion | Series B Preferred Stock | 600k | $0.00 | $0 | See Footnotes | 04/08/2019 |
| 04/08/2019 | NGM BIOPHARMACEUTICALS INC | NGM | Conversion | Series A Preferred Stock | 3M | $0.00 | $0 | See Footnotes | 04/08/2019 |
| 04/08/2019 | NGM BIOPHARMACEUTICALS INC | NGM | Conversion | Common Stock | 3.8M | $0.00 | $0 | See Footnotes | 04/08/2019 |
| 06/09/2015 | Anacor Pharmaceuticals, Inc. | ANAC | Grant | Common Stock | 794 | $0.00 | $0 | | 06/09/2015 |
| 06/09/2015 | Anacor Pharmaceuticals, Inc. | ANAC | Grant | Stock Option (right to buy) | 4.1k | $69.40 | $284.3k | | 06/09/2015 |
| 08/27/2014 | Anacor Pharmaceuticals, Inc. | ANAC | Sale | Common Stock | 13.1k | $22.50 | $294k | | 08/27/2014 |
| 05/29/2014 | Anacor Pharmaceuticals, Inc. | ANAC | Grant | Stock Option (right to buy) | 15k | $14.22 | $213.3k | | 05/29/2014 |
| 02/03/2014 | Anacor Pharmaceuticals, Inc. | ANAC | Other (acquisition) | Common Stock | 13.1k | $0.00 | $0 | | 05/29/2014 |
| 05/30/2012 | Anacor Pharmaceuticals, Inc. | ANAC | Grant | Stock Option (right to buy) | 15k | $5.20 | $78k | | 05/30/2012 |
| 03/31/2011 | Anacor Pharmaceuticals, Inc. | ANAC | Grant | Stock Option (right to buy) | 30k | $6.92 | $207.6k | | 03/31/2011 |